Pharmaceutical Supply – DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES (25 MG)

The contract involves the supply and delivery of 11,000 bulk tins of DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES, USP, 25 MG, 100S, requiring strict adherence to labeling, packaging, and hazardous material handling standards to ensure regulatory compliance and safety during transport and storage. The product is intended for use by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance obligations centered at Fort Bragg, North Carolina, under the NAICS code 325412 for pharmaceutical and biological product manufacturing. All deliveries must meet federal requirements for controlled substances and hazardous material logistics, including proper documentation, secure packaging, and compliance with DOT and FDA regulations. The solicitation was posted on July 15, 2026, with a response deadline of July 21, 2026, indicating a narrow window for interested suppliers to submit proposals. This is a subcontract opportunity, not directly competitive under a public solicitation, and there is no set-aside designation specified, meaning all qualified vendors may respond regardless of business size or categorization. Suppliers must access the official DIBBS platform via the provided link to obtain full procurement details and submit responses in accordance with the agency’s procedural guidelines. Failure to comply with packaging, labeling, or hazardous material standards could result in rejection of bids or non-compliance penalties post-award.